moexiprilat has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doevendans, PA; Grohé, C; Meyer, R; Schlüter, KD; Schreckenberg, R; van Eickels, M | 1 |
| Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H | 1 |
2 other study(ies) available for moexiprilat and Hypertension
| Article | Year |
|---|---|
The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Estradiol; Estrogens; Female; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Ovariectomy; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Endomyocardial Fibrosis; Estradiol; Estrone; Female; Fibroblasts; Gene Expression; Genes, fos; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Menopause; Myocardium; Rats; Sp1 Transcription Factor; Tetrahydroisoquinolines | 1998 |